ABT
Abbott Laboratories
Company Overview
| Mkt Cap | $220.36B | Price | $123.62 |
| Volume | 7.05M | Change | -0.84% |
| P/E Ratio | 16.4 | Open | $123.84 |
| Revenue | $42.0B | Prev Close | $124.67 |
| Net Income | $13.4B | 52W Range | $110.86 - $141.23 |
| Div Yield | 2.36% | Target | $146.29 |
| Overall | 56 | Value | 95 |
| Quality | -- | Technical | 18 |
No chart data available
Stock Overview
Updated DailyAbbott Laboratories (ABT) is a leading Healthcare company in the Medical Devices industry, currently trading at $123.62 with a market capitalization of $220.36 billion. The stock is trading in the middle of its 52-week range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows ABT with a volume of 7.05 million shares. The stock opened down 0.67% from yesterday's close of $124.67. Current analyst estimates project earnings of $5.15 per share for this year, with next year targeting $5.67.
ABT demonstrates concerning technical signals based on technical analysis. The company trades on the NYE exchange and operates alongside industry peers including JNJ, PFE, MDT, TMO, BMY.
Key investment considerations for ABT include average overall investment profile. The company offers a dividend yield of 2.36% and analyst price targets suggest potential upside of 18.3%. The stock shows attractive valuation opportunity based on valuation analysis.
Analysis generated on November 2, 2025 at 12:04 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ABT | $123.62 | -0.8% | 7.05M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |